Business Context and Reporting Period
This Form 8-K Current Report was filed by Dollar General Corporation on April 19, 2023. The filing primarily addresses Item 5.02 regarding the departure of certain officers and the appointment of new officers, specifically the transition of the Chief Financial Officer (CFO) role.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and employment terms.
Material Changes
The filing details the following material changes to executive leadership and compensation:
- CFO Transition: John W. Garratt, President and CFO, will retire effective June 2, 2023. He is relinquishing the CFO title effective May 1, 2023, to facilitate a transition.
- New CFO Appointment: Kelly M. Dilts, previously Senior Vice President of Finance, has been promoted to Executive Vice President and Chief Financial Officer, effective May 1, 2023.
- Compensation Adjustments for Ms. Dilts:
- Annual base salary increased from $676,794 to $750,000.
- Targeted annual incentive opportunity increased from 50% to 75% of base salary.
- Award of a one-time long-term incentive (non-qualified stock options) with an approximate value of $878,297, vesting ratably over four years.
- Employment Agreement: A new agreement was entered into with an initial term extending to March 31, 2024, subject to automatic extensions.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary on business operations. Regarding risks and contingencies, the new Employment Agreement includes standard provisions for termination without cause or resignation for good reason, which would entitle Ms. Dilts to:
- 24 months of continued base salary payments.
- A lump sum payment equal to two times the average percentage of target bonus paid in the two most recent fiscal years, multiplied by her target bonus level and base salary.
- A lump sum payment equal to two times the annual company contribution for medical, pharmacy, dental, and vision benefits.
- Reasonable outplacement services for up to one year.
Investor Verification Checklist
- Verify the exact vesting schedule and grant date for the $878,297 stock option award in the attached Exhibit 99.1 and 99.2.
- Confirm the specific definitions of "without cause" and "good reason" within the new Employment Agreement to understand severance triggers.
- Review the press release (Exhibit 99.3) for any additional context on the strategic rationale for the leadership change.
- Note that this filing contains no financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.